Study of Obeldesivir in Nonhospitalized Participants With COVID-19

Completed · Phase 3 · Has a placebo group

Conditions studied: COVID-19

In brief

The goal of this clinical study is to test if obeldesivir (GS-5245) is safe and effective for the treatment of coronavirus disease 2019 (COVID-19) in participants who have a standard risk of developing severe illness. This study will also measure how much obeldesivir gets into the blood and how long it takes for the body to get rid of it.

Key facts

Study ID
NCT05715528
Run by
Gilead Sciences
People needed
2011
Starts
2023-02-08
Expected to finish
2024-01-23
Last updated by the study team
2024-12-24

Who can join

Age: 12 and older, up to 64. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.